R

Repare Therapeutics
D

RPTX

2.79000
USD
-0.18
(-6.06%)
Market Closed
Volume
3,074
EPS
-2
Div Yield
-
P/E
-1
Market Cap
118,604,875
OverviewSignalsIdeasNews
Related Instruments
    A
    ALDX
    -0.06000
    (-1.41%)
    4.20000 USD
    A
    ARCT
    -2.310
    (-12.60%)
    16.020 USD
    A
    ARWR
    -2.890
    (-13.49%)
    18.540 USD
    A
    ASND
    2.160
    (1.74%)
    126.510 USD
    B
    BLUE
    -0.04270
    (-11.74%)
    0.32090 USD
    B
    BNTX
    -3.740
    (-3.61%)
    99.740 USD
    C
    CRSP
    0.360
    (0.77%)
    47.280 USD
    E
    EDIT
    -0.11500
    (-4.14%)
    2.66500 USD
    More
News

Title: Repare Therapeutics

Sector: Healthcare
Industry: Biotechnology
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations. The company derives maximum revenue from Canada.